Denali Therapeutics Inc
Closed
SectorHealthcare
19.5 -1.02
Overview
Share price change
24h
Min
19.5
Max
20.42
Income | -1.6M -129M |
|---|---|
Employees | 503 |
EBITDA | 8.9M -125M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +80.82% upside |
Next Earnings | 11 May 2026 |
|---|
Market Cap | -295M 3B |
|---|---|
Previous open | 20.52 |
Previous close | 19.5 |
News Sentiment
By Acuity
29%
71%
86 / 347 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Denali Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Denali Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 35.64 USD 80.82%
High 42 USD
Low 23 USD
Based on 14 Wall Street analysts offering 12 month price targets forDenali Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$